Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armscote Investment Company is a private investment and holding firm primarily known for its significant ownership stakes in the global pharmaceutical industry. It serves as a principal vehicle for the Sackler family's interests, holding major positions in entities such as Purdue Pharma L.P. and the Mundipharma network. The company's portfolio focuses on therapeutic areas including pain management, oncology, and respiratory medicine. Historically, Armscote has played a central role in the strategic and financial management of these pharmaceutical assets across international markets. In recent years, the company has been a focal point in legal proceedings and restructuring efforts related to the opioid crisis and the subsequent bankruptcy of its primary subsidiaries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Armscote Investment Company.